Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Can someone share the link to the action group?
Anyone know what the timelines are before we hear an update from Administrators? Anyone know what is typical timelines in a similar situation?
My understanding is directors have to carry significant insurance also
Do you have content in the link. I cannot access it. Is DDDD mentioned?
Thanks!!
Any idea how DDDD can tap into this government funding time?
Separately I contacted my accountant and he sent me the following link to information on administration:
https://www.gov.uk/put-your-company-into-administration
Is this breakthrough treatment under DDDD or has Duncan other interests in other companies going on?
What’s next steps here. I support pursuing DDDD/DP as a combined shareholder battle. I have a lot to lose if DDDD is gone. A combined effort may carry more weight.
I am one of the bigger losers, along with numerous others I am sure. Everyone that has lost something is at a loss. Everyone invested knowing the risk, but when you are seeing impressive presentations about good results and blockbuster drugs like Keytruda linked to it, it’s hard not to think this was the next big thing. There was also the link to Parkinson’s. All very impressive collaborations. Did anyone contact Interpath about DDDD? CRL you mentioned this over the weekend. Sorry if you posted an update, I didn’t see one. Is there something we can do for all shareholders or is this each man/women for themselves?
When I read about the Pfizer buyout of Bind, it says:
‘Pfizer Inc. won bankruptcy-court approval Wednesday to buy the assets of Bind Therapeutics after an auction doubled Pfizer’s starting offer, for a final price of $40 million.
The results mean estimated profits of $22.5 million to be divided among Bind shareholders, company lawyer Peter Gilhuly said at the Wednesday court hearing when the sale was approved.’
Would the shareholders have received payout or would they have got Pfizer shares?
Thanks CRL. Interpath certainly look like a company that can help in this situation. Do we as shareholders have any influence here? How do we find out what Duncan is doing ?
So DDDD had investors from MERCK to Pfizer and others. If one of these bought them out or someone else, and continued the trials, would we as shareholders of DDDD lose our shares? Or would this all boil down to what the purchase agreement ended up being ?
Have Interpath worked for other companies …. Did Redx use Interpath?
I am just reading what ms happened now. I am gutted like everyone and trying to get my head around it.
What happened to the shareholders that had bought into Redx before they went into administration ? Did the shareholders lose their shares?
Does anyone know for sure if we have lost everything, or is everyone just speculating right now?
Is Duncan obliged to give any announcement or update? When I Google it there is not much out there about it.
Anyone know what the ticker FRPRF for 4D is? My understanding is that the Nasdaq ticker is LBPS.
Anyone know what the ticker FRPRF for 4D is? My understanding is that the Nasdaq ticker is LBPS.
I don’t know if there will ever be a scenario where the US stocks outrun UK stocks and we're forced to convert them. That is my question also. I assume if they went all Nasdaq then they would have to convert our AIM shares i.e. we would not lose anything and would just convert over to Nasdaq.
I reached out to 4D and this is feedback I got.
So is there any risk to keeping the shares in AIM over the Nasdaq. AIM is said to be a riskier stock but I don’t know if it’s just related to riskier companies rather than the stock itself.
If they had dividends would there be dividends in one and not in the other?
Anyone know is there is any impact due to Brexit and the share type we hold i.e. AIM versus Nasdaq?
I am new on here. I recently bought dddd shares as I am very excited about their pipeline. What I am not clear on is when they float on the Nasdaq. I have been informed that the current shareholders can switch their shares to the Nasdaq or stay on the AIM stock market. Current 4D shares will continue to exist and to trade on AIM under the ticker DDDD as they are. As part of the Longevity merger terms, new shares will be issued as American Depositary Shares (ADSs), which are simply shares ‘bundled’ together (1 ADS = 8 Ordinary Shares) and this is the standard way in which shares of non-US companies are traded on US exchanges; the ADSs will begin trading on NASDAQ under the ticker ‘LBPS’ on completion of the merger.
As a current holder of 4D ordinary shares you do not need to do anything. If shareholders wish, they may convert their ordinary shares to ADSs to be traded on NASDAQ, please contact your broker for more information about this process.
So my question is are you better swopping to the Nasdaq shares or remaining on the AIM stockmarket? What are peoples views? What would be the long-term for the AIM shares compared to the Nasdaq shares? Is the AIM riskier to stay on?